Description

Studies indicate that VIP can lower inflammation throughout the body, with especially notable benefits in conditions such as neurodegenerative disorders, pulmonary fibrosis, inflammatory bowel disease, and cardiac fibrosis. The peptide seems to act effectively across multiple fibrotic pathways and may provide therapeutic value in the widespread fibrotic processes that contribute substantially to illness and death. Beyond its antifibrotic activity—thought to work largely through its anti-inflammatory mechanisms—VIP is also a strong modulator of the immune system and a broad-spectrum anti-inflammatory agent. Research has additionally shown that VIP helps protect the central nervous system from damage and is being actively explored for its potential to support cognitive function in neurodegenerative disease contexts.